These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7237462)

  • 1. Therapy for advanced colorectal cancer with a combination of 5-FU and anguidine: a Southwest Oncology Group Study.
    Goodwin W; Stephens R; McCracken JD; Groppe C
    Cancer Treat Rep; 1981; 65(3-4):359. PubMed ID: 7237462
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of anguidine in gastrointestinal malignancies: a Southwest Oncology Group study.
    Bukowski R; Vaughn C; Bottomley R; Chen T
    Cancer Treat Rep; 1982 Feb; 66(2):381-3. PubMed ID: 7055820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melphalan, vincristine, and 5-FU in advanced colonic carcinoma: results of a pilot study.
    Ashenhurst J; Bitran JD; Robin E; Desser RK; Shapiro C; Kozloff MF; Billings AA
    Cancer Treat Rep; 1981; 65(9-10):869-72. PubMed ID: 7273020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
    Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine and 5-FU: a Phase II pilot study in colorectal and breast carcinomas.
    Presant CA; Multhauf P; Klein L; Chan C; Chang FF; Hum G; Joseph R; Opfell R; Lemkin S; Shiftan T; Plotkin D
    Cancer Treat Rep; 1983; 67(7-8):735-6. PubMed ID: 6871891
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of 5-FU melphalan in advanced colorectal carcinoma.
    Gough IR; Furnival CM; Thynne GS; Burnett W
    Cancer Treat Rep; 1981; 65(7-8):735-6. PubMed ID: 7248993
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of anguidine in patients with sarcomas unresponsive to prior chemotherapy: A Southwest Oncology Group Study.
    Thigpen JT; Vaughn C; Stuckey WJ
    Cancer Treat Rep; 1981; 65(9-10):881-2. PubMed ID: 7273022
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lethal and cytokinetic effects of anguidine on a human colon cancer cell line.
    Dosik GM; Barlogie B; Johnston DA; Murphy WK; Drewinko B
    Cancer Res; 1978 Oct; 38(10):3304-9. PubMed ID: 688220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-FU, methotrexate, and mitomycin in advanced colorectal adenocarcinoma: a phase II study.
    Biran H; Sulkes A; Biran S
    Cancer Treat Rep; 1981; 65(9-10):924-5. PubMed ID: 7273031
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of chemotherapy in the treatment of advanced colorectal cancer--pilot study of 5-FU by biochemical modulation].
    Katsumata K; Yamamoto K; Ohno M; Shibata K; Yamashita S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):459-64. PubMed ID: 8678498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-fluorouracil by protracted subcutaneous infusion. A pilot study.
    Zaniboni A; Meriggi F; Alghisi A; Marini G
    J Infus Chemother; 1995; 5(2):67-9. PubMed ID: 8521237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II evaluation of anguidine (NSC 141537) in 5-day courses in colorectal adenocarcinoma. A Southeastern Cancer Study Group Trial.
    DeSimone PA; Greco FA; Lessner HF; Bartolucci A
    Am J Clin Oncol; 1986 Jun; 9(3):187-8. PubMed ID: 3728370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship of serum level of dihydropyrimidine dehydrogenase and serum concentration of 5-fluorouracil to treatment response and adverse events in colorectal cancer patients].
    Dong QM; He YJ; Li S; Zhou ZM; Zhang L; Zhou ZW; Xia ZJ; Li YY
    Ai Zheng; 2005 Apr; 24(4):483-7. PubMed ID: 15820075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biweekly low-dose cisplatin and 5-fluorouracil combination chemotherapy for advanced gastrointestinal carcinoma].
    Kamata T; Morita A; Nakamoto A; Onishi I; Takeda T; Koyasaki N; Kanno M
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):859-64. PubMed ID: 10897212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292).
    Wadler S; Bajaj R; Neuberg D; Agarwal V; Haynes H; Benson AB
    Cancer J Sci Am; 1997; 3(5):284-8. PubMed ID: 9327152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical modulation of 5-FU--effect of low dose CDDP].
    Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU.
    Vogl SE; Qazi R; Berenzweig M
    Cancer Treat Rep; 1980; 64(10-11):1143-5. PubMed ID: 7459902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.